Lataa...
An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line
The phenomenon of acquired resistance to chemotherapeutic agents is a long-standing conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave the way for the development of novel strategies, we generated a PC3 prostate cancer cell line resistant to proteasome inhibitor bor...
Tallennettuna:
| Julkaisussa: | Cytotechnology |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Netherlands
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7002631/ https://ncbi.nlm.nih.gov/pubmed/31863311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-019-00362-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|